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ABSTRACT
Objectives To evaluate the usability and acceptability of 
an electronic consent pilot intervention for school- based 
immunisations and assess its impact on consent form 
returns and human papilloma virus (HPV) vaccine uptake.
Design Mixed- methods theory- informed study applying 
qualitative methods to examine the usability and 
acceptability of the intervention and quantitative methods 
to assess its impact.
Setting and participants The intervention was piloted 
in 14 secondary schools in seven London boroughs in 
2018. Intervention schools were matched with schools 
using paper consent based on the proportion of students 
with English as a second language and students 
receiving free school meals. Participants included 
nurses, data managers, school- link staff, parents and 
adolescents.
Interventions An electronic consent portal where 
parents could record whether they agreed to or declined 
vaccination, and nurses could access data to help them 
manage the immunisation programme.
Primary and secondary outcome 
measures Comparison of consent form return rates and 
HPV vaccine uptake between intervention and matched 
schools.
Results HPV vaccination uptake did not differ between 
intervention and matched schools, but timely consent 
form return was significantly lower in intervention 
schools (73.3% vs 91.6%, p=0.008). The transition to 
using electronic consent was not straightforward, while 
schools and staff understood the potential benefits, they 
found it difficult to adapt to new ways of working which 
removed some level of control from schools. Reasons for 
lower consent form return in e- consent schools included 
difficulties encountered by some parents in accessing 
and using the intervention. Adolescents highlighted 
the potential for electronic consent to by- pass their 
information needs.
Conclusions The pilot intervention did not improve 
consent form return or vaccine uptake due to challenges 
encountered in transitioning to new working practice. 
New technologies require embedding before they become 
incorporated in everyday practice. A re- evaluation once 
stakeholders are accustomed with electronic consent may 
be required to understand its impact.
INTRODUCTION
Vaccination against human papilloma virus 
(HPV) provides long- term protection against 
cervical and other cancers and genital 
warts.1 2 In England, HPV vaccination (two 
doses 6 months apart) is offered to adoles-
cents aged 12–14 years in the school- based 
immunisation programme, which is delivered 
by nurse- led immunisation teams. While the 
school delivery model is widely accepted,3 
it raises logistical challenges regarding 
obtaining parental consent. Immunisation 
teams and schools identify all students, who 
are eligible for vaccination and then students 
are typically given a paper consent form that 
their parents/legal guardians need to sign 
Strengths and limitations of this study
 ► The use of a theory- informed mixed- methods study 
design allowed us to measure the effect of a pilot e- 
consent intervention on immunisation performance 
and identify mechanisms that facilitated or impeded 
implementation.
 ► The study design allowed us to account for schools, 
nurses, data managers, parents and adolescents’ 
experiences of using the e- consent technology in 
this evaluation.
 ► Data limitations include the lack of interviews with 
school staff to complement the feedback forms and 
not being able to access and interview parents, who 
found the intervention more challenging to use.
 ► This evaluation was limited to one cycle of imple-
mentation, which did not allow us to account for the 
time it takes for new practices to become embed-
ded. The number of schools who declined to pilot the 
intervention was also not recorded.
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indicating their acceptance or refusal of vaccination. The 
passage of the form from teachers to students to parents 
and back again can impact on form return and have a 
detrimental effect on vaccine uptake.4–7 Follow- up by 
school staff and immunisation teams improves uptake but 
is resource intensive.8 9 In the context of the drive towards 
a ‘paperless National Health Service (NHS)’,10 there is 
increasing interest in the potential for technological solu-
tions, such as electronic consent (e- consent). We evalu-
ated the usability and acceptability of a pilot e- consent 
intervention from the perspective of parents and adoles-
cents, health professionals and schools, and assessed its 
impact on consent form returns and HPV vaccine uptake.
The electronic consent intervention
The e- consent intervention was developed by Houn-
slow and Richmond Community Healthcare NHS Trust 
(HRCH) with the support of a software development 
company in 2017/2018 and piloted in their adolescent 
girls’ vaccination programme in June/July 2018. At the 
time of the study, HRCH was responsible for adminis-
tering this vaccination programme in secondary schools 
across eight boroughs in South London.
The e- consent intervention consisted of an online 
portal with an e- consent form and a data platform and 
related implementation procedures (figure 1). Function-
ally it aimed to: (1) give parents access to an online portal 
with information about the vaccination programme 
where they could register their adolescent and agree to 
or decline HPV vaccination; (2) give nurses electronic 
access to the portal to facilitate screening and enable 
them to update records during immunisation sessions; (3) 
enable automatic updating of central vaccination record 
databases. Parts of the online portal and data platform 
(specifically those relating to points 2 and 3) were not 
fully functioning before the intervention was first used in 
June 2018. Hence modifications had to be made to the 
way nurses screened students’ information and consent 
forms before and during immunisation sessions. Figure 1 
differentiates what happened in Year 1: June/July 2018 
and in Year 2: June/July 2019 (blue text).
In the quantitative part of evaluation, we focused on 
year 1; the measurement of outcomes and impacts. In the 
qualitative part of the evaluation we captured how year 
1 experience informed adaptations to the intervention 
prior to reuse in year 2.
METHODS
Study design
This was a mixed- methods theory- informed evaluation 
study which used a ‘Theory of Change’ (figure 2) as an 
evaluation framework. Quantitative methods were used to 
assess whether the pilot intervention increased consent 
form return and the uptake of the first dose of HPV 
vaccine in adolescent girls in June/July 2018 (year 1). 
The steps involved in implementing the e- consent system, 
people’s experiences of these, the interactions between 
inputs, activities, pathways and outputs, outcomes and 
Figure 1 The electronic consent intervention.
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impacts were investigated using qualitative methods in 
year 1 and Year 2. The reason that the quantitative analysis 
only focused on year 1 was that the schools that received 
the intervention between year 1 and 2 changed.
School selection
The e- consent intervention was piloted in 14 secondary 
schools in seven South London boroughs in June/July 
2018 (year 1). Schools selection was purposive with the 
aim of including schools that differed in terms of denomi-
nation (private, state, grammar), type (mixed, single sex), 
sociodemographic, size, vaccination uptake and level of 
support to the programme.
Schools were divided into low, medium or high based 
on the proportion of pupils receiving free school meals 
and with English as an additional language. Each e- con-
sent school was matched, as closely as possible, to a paper 
consent school in the same tertiles for both characteristics.
Quantitative methods and analysis
Data collection (year 1)
At each vaccination session nurses completed a ‘tally 
sheet’, with details of the consents received prior to or 
during the session, any absences and the number of 
vaccinations given. These tally sheets were completed for 
paper and e- consent schools.
In addition, we extracted the name of the school, date 
and time of consent form completion and type of consent 
(agreement by parent or adolescent self- consent or 
decline) for each consent form in the e- consent system. 
This non- identifiable information was combined with 
tally sheet data, which was manually transcribed into MS 
Excel. Where there were discrepancies or missing data 
this was checked with the immunisation teams and in the 
case of the e- consent schools the system data was used in 
preference to the tally sheet data.
Data analysis
Characteristics of the paper and e- consent schools 
were described in terms of proportion of pupils 
receiving free school meals, speaking English as an 
additional language, ethnicity and characteristics of 
the schools (religious affiliation and state/privately 
funded), using data from the Office of National Statis-
tics. (REF: https://www. gov. uk/ government/ statistics/ 
schools- pupils- and- their- characteristics- january- 2018).
For both paper and e- consent schools, we calculated: 
(1) the proportion of the pupils for whom a consent form 
had not been returned prior to the vaccination session, 
(2) the proportion of pupils vaccinated at the planned 
session and (3) the proportion of pupils for who a ‘yes’ 
consent was received (prior to or on the day of the 
planned vaccination session).
We compared e- consent schools with paper consent 
schools in terms of timely form return, outcome of 
consent and vaccination uptake using Kruskal- Wallis tests 
for statistical significance. Where data were missing from 
a school that school and its matched pair were excluded 
from the analysis. All analyses were done in MS Excel and 
Stata V.15.
Figure 2 Theory of change for the e- consent intervention.HPV, human papilloma virus.
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Qualitative methods & analysis
Data collection
Data collection occurred in June–December 2018 (year 
1) and June–July 2019 (year 2). The first period coincided 
with and followed the first year of e- consent implementa-
tion, the second occurred during the use of e- consent in 
a different subset of schools.
June–July 2018 (year 1)
Observations of e-consent school HPV immunisation sessions
Members of the evaluation team (RC, TC and SM- J) 
accompanied immunisation teams during seven e- consent 
school HPV immunisation sessions to obtain a contextual 
understanding of the implementation of the interven-
tion. The evaluators documented what worked well and 
what if any problem solving was applied during sessions.
School feedback forms from paper and e-consent schools
School staff involved in organising immunisation sessions 
were asked to complete a feedback form after the HPV 
immunisation sessions (online supplemental additional 
file 1). Forms included questions about the organisation 
of immunisation sessions and the usability and accept-
ability of e- consent and paper consent. Seven e- consent 
and seven paper consent schools completed forms.
Individual and peer group interviews with HRCH staff
These semistructured interviews (SSI’s) involved HRCH 
staff who were responsible for implementing the interven-
tion. The programme manager was interviewed individu-
ally, the two data specialists together and member of four 
immunisation teams in peer groups of two to four partici-
pants (12 interviewees) at their respective offices. In total 
15 members of staff took part in hour long interviews.
Interviews with parents and adolescents from e-consent schools
These SSIs involved parents and adolescents who had 
used the e- consent system. Parents/legal guardians were 
asked to indicate their willingness to be contacted by 
researchers in the e- consent form (ticked a statement). 
Parents who responded positively were invited by email 
to take part in an interview to discuss their experience of 
using the e- consent system. A total of 12 interviews were 
conducted, nine with HPV vaccine acceptors and three 
with decliners. Four interviews were conducted in family 
homes, seven by telephone, and one by Skype video. 
Adolescents participated in five interviews.
June–July 2019 (year 2)
Results from data collected in year 1 informed the imple-
mentation of the e- consent intervention in 22 schools 
located in South London in the 2018/2019 HPV vaccine 
programme. Only one of these schools had taken part in 
the 2018 pilot, the reasons for using the improved inter-
vention in this school and not the other pilot schools 
was mainly due to the scheduling of the HPV vaccina-
tion sessions. The Trust also wanted to expose additional 
schools to the e- consent system. To reflect the changes 
made to the intervention and its implementation two 
group interviews with HRCH staff (one with nine and the 
other with five members of staff) and one focus group 
discussion (FGD) with eight adolescent girls (from a 
school that used the e- consent intervention in 2019 only) 
were conducted.
The topics covered in the staff, parent and adolescent 
SSIs and adolescent FGD are summarised in table 1 (see 
online supplemental additional file 2 for topic guides).
Data analysis
The SSIs and FGD were audio recorded with participant’s 
permission and transcribed anonymously. Transcripts, 
observational field notes and school feedback forms were 
downloaded into a qualitative data analysis management 
software program (NVivo V.12). We adopted a thematic 
analytical approach which combined semideductive 
mapping of data to the ‘input’, ‘activities’, ‘pathways’, 
‘outputs’, ‘outcomes’ and ‘impacts’ depicted in the 
Theory of Change (ToC) and inductive open coding to 
capture emerging themes.11 We sought to account for the 
interdependence of ToC categories and real- life experi-
ence of managing organisational change, which do not 
always progress from inputs—impacts in a seamless linear 
manner.
Patient and public involvement
This evaluation was designed with members of HRCH 
who were responsible for coordinating the implemen-
tation of the e- consent intervention. This collabora-
tion supported the iterative and reflexive development 
Table 1 Topics covered in interview
Staff interviews Parent and adolescent interviews
 ► Experience of managing the administration of the school- 
based vaccination programme.
 ► Experience of obtaining consent in school- based 
vaccination programme.
 ► Acceptability and usability of the e- consent system.
 ► Interaction between schools and immunisation teams.
 ► Adolescent self- consent.
 ► Reflections on use of the e- consent system.
 ► Views on adolescent vaccination.
 ► Understanding of adolescent vaccination.
 ► Experience of providing consent for the HPV vaccine.
 ► Acceptability and usability of the e- consent system.
 ► Teenagers experience of immunisation in school.
 ► Vaccine programme communication.
 ► Views on adolescent self- consent.
HPV, human papilloma virus.
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of the intervention, which is essential for longer- term 
integration.
RESULTS
Quantitative
Participants
Twenty- eight schools (14 paper and 14 e- consent schools) 
comprising 3219 girls (1733 in paper consent and 1486 in 
e- consent schools) were included in the study. Of those 
schools, 26 were state and 2 were private schools. Twen-
ty- one of the schools had no religious affiliation, three 
were Roman Catholic (all paper consent), three Church 
of England (two e- consent, one paper consent) and one 
was another Christian faith school (paper consent).
The proportion of pupils eligible for free school meals, 
with English as an additional language and students’ 
ethnicity profile was similar between the e- consent and 
paper consent schools (table 2).
Return of consent forms ahead of session
Overall, 83% of consent forms (paper or e- consent) 
were returned prior to the vaccination session. However, 
among the 22 matched schools where this data was 
available, compared with paper schools timely (prior to 
the planned session) return was lower in the e- consent 
schools (73.3% vs 91.6%, p=0.008).
Outcome of consent
There was no statistically significant difference in the 
proportion of pupils for whom a ‘yes’ consent was received 
(prior to or on the day of the session) between the paper 
(n=14) and e- consent (n=14) schools (85% in e- consent 
schools, 83% in paper consent schools, p=0.89).
Vaccination uptake
There was no statistically significant difference in the 
proportion of pupils that were vaccinated at the sched-
uled vaccination session between the paper (n=14) and 
e- consent (n=14) schools (80.6% vs 81.3%, p=0.93). 
These figures did not include those who were absent 
on the day and vaccinated later (Paper consent would 
have been used in the 14 control schools at school and 
community based catch up clinics. All parents in e- con-
sent schools would have received the weblink to the 
e- consent portal and in most cases will have used this 
link to complete the consent form. Some students who 
attended e- consent school catch up clinics did not have 
a signed e- consent form. In those instances, the nurses 
would phone parents during clinics or obtain adolescent 
self- consent if appropriate. In the case of community- 
based catch up clinics parents/guardians and students 
would usually attend together, if the e- consent had not 
been completed nurses would either complete the e- con-
sent form at the clinic with the parent and student, if 
Wifi/technology was available or complete a paper 
consent form). The final vaccine uptake across all the 
schools was over 86%.
Qualitative
The results of the ToC thematic analytical mapping are 
presented under relevant headings (‘input’, ‘activities’, 
‘pathways’, ‘outputs’, ‘outcomes’), followed by an overar-
ching theme on managing change.
Inputs
Resources and training
There was a ‘buzz’ about the development of the e- consent 
intervention, its potential to streamline consent and facil-
itate safer data collection and NHS England had provided 
funding for HRCH to pilot it during the 2017/2018 HPV 
vaccine programme. Immunisation team members were 
positive but expressed reservations about not able to 
review paper consent forms prior to immunisation. Due 
to tight deadlines only one orientation session took place 
before the e- consent intervention was introduced, which 
meant that the bulk of learning happened on the job.
I think as well, it was probably four days before our 
first session, we didn’t know what we were doing…
so I do feel we are running before we can walk. 
(Immunisation Team 2)
Intervention not fully operational
The data platform component of the online portal was 
not operational prior to implementation. Parents were 
able to access and complete the e- consent form, but the 
immunisation teams could not review student’s online 
consent forms or upload data during immunisation 
sessions. Instead large (A3) paper sheets with information 
about who had provided consent were prepared by the 
data managers. The sheets were difficult for to decipher 
during busy sessions and nurses were less able to prepare 
cohort figures and tally sheets in advance.
It was an anti- climax not being able to use the lap-
tops and still have a paper sheet in front of me. 
(Immunisation Team 4)
Table 2 Characteristics of paper and e- consent schools† ‡
Paper consent 
schools (n=13)
E- consent 
schools (n=13)
P 
value*
% (range) of children 
eligible for free school 
meals
17.3 (1.5–52.1) 17.3 (1.5–43.2) 0.84
% (range) of children 
with English as 
additional language
30.9 (5.5–53.6) 32.4 (9.1–59.2) 0.72
% (range) of children of 
white British ethnicity
30.9 (1.5–69.6) 34.6 (6.3–65.7) 0.63
*Refers to comparison of each characteristic using Kruskal- Wallis 
test.
†Characteristics information was not available for the two private 
schools.
‡Data from Schools, pupils and their characteristics: January 2018, 
Department of Education.
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Mobilising and resourcing schools
There was limited time to collaborate with schools before 
the vaccination programme, although all e- consent 
schools were guided on how to disseminate the weblink. 
A few schools in two inner city boroughs declined to use 
the intervention due to concerns about: (1) pre- existing 
barriers to electronic communication with parents, (2) 
whether a change to consent processes would reduce the 
return of consent forms and uptake of HPV vaccine and 
(3) adapting to a new way of working.
School immunisation link staff reported a ‘loss of 
control’, for example, they could no longer see ‘who 
had said yes, and who had said no’, which restricted their 
ability to follow- up unreturned forms. Paper- consent 
schools could monitor this directly by counting forms, 
but with e- consent schools immunisation teams had to 
check parental responses and tell schools which families 
had not replied.
Activities
Dissemination of the online e-consent portal weblink to parents
E- consent schools used different means (parent mail, 
email, school website, newsletters, letters) to send 
parents the portal weblink. Blanket reminders were 
mainly sent electronically, unless immunisation teams 
provided schools with details of non- responders. In this 
case follow- up could be more targeted and involve text 
messages and phone calls as wells as emails. One school 
used a translator to engage parents who did not under-
stand the consent process due to language barriers. 
Another school was not willing to send out emails and 
asked the immunisation team to provide them with 
printed letters referring to the weblink to send to parents.
Of the seven e- consent schools who completed the feed-
back form, four were positive about the intervention and 
how it had been implemented stating that it had reduced 
their workload. Another school was mainly positive but 
noted that some parents had found the e- consent form 
difficult to access, another reported that their parent 
cohort had found the system very difficult to access and 
use, and the last school was the one who had used letters 
to disseminate the weblink.
Pathways
Navigating the e-consent form and related information
The e- consent form included links to an HPV vacci-
nation leaflet. However, none of the interviewees had 
downloaded or read this leaflet for the following reasons: 
accessed information elsewhere, already sufficiently 
informed, older daughter vaccinated, positive about 
vaccination.
Proactive information seeking involving a wider range 
of sources was more common in families who were vaccine 
hesitant. Their concerns, which in some cases resulted 
in vaccine refusal, included the following: (1) compati-
bility of vaccination with pre- existing illness, (2) unknown 
side effects (eg, hormonal interferences while daughter 
establishing her cycle), (3) targeting of adolescents due 
to their ethnicity (nurses explained that some parents of 
Black- Caribbean origin were sceptical of any state inter-
vention, like vaccination) and (4) necessity of vaccina-
tion for adolescents who are not sexually active. Parents 
who were more confident about vaccines restricted their 
information seeking to NHS sources and suggested that 
a ‘road map’ to adolescent vaccination could be useful.
Adolescents reported a variety of information seeking 
behaviours. Some just accepted HPV vaccination as 
‘something that needs to be done’ and felt reassured that 
it was recommended by the NHS: ‘I think because it’s 
like by the NHS—it kind of gives it validation.’ (Adoles-
cent 9—Yes). Others wanted the HPV vaccine leaflet to 
include more information about HPV and related health 
risks and vaccine side effects, so that they did not panic if 
they experienced any of these.
In the FGD students expressed a preference for paper 
leaflets and discussed how the e- consent could bypass 
them: ‘…because like if it’s emailed, like your mum 
doesn't have to share it with you. And like if I have some-
thing done like an injection, I’d like to know what’s going 
on and when. But like she filled out the form without like 
telling me, so like if they’d been given out in school then 
I could have read it and see what’s happening.’
These FGD participants wanted to have the opportu-
nity to discuss vaccination with their parents; they were 
not seeking autonomy in decision making rather wanted 
a degree of joint responsibility.
I wouldn’t like to be given the option to like not to 
have the injection done…so I’m kind of glad that 
my mum just decided like on her own. But I would 
have liked her to talk it through with me… (FGD 
participant)
Parents approaches to talking to their daughters about 
having an HPV vaccination are summarised in box 1.
Using the e-consent intervention
The parents we interviewed found the system easy to use 
and usually completed the form as soon as they received 
Box 1 Parents approaches to discussing human 
papilloma virus vaccination with adolescent daughters
Very limited discussion
 ► Did not talk to daughter in detail since vaccination is a parental 
decision.
 ► Talking too much about pending vaccination may induce anxiety, 
especially if needle phobic.
Heads up as what to expect
 ► Ensured daughter knew what to expect; this exchange usually oc-
curred shortly before the immunisation session.
 ► Offered to answer any questions depending on adolescents’ desire 
to know more.
More in- depth discussions
 ► Joint decision making between parents and adolescents about the 
important of vaccination, this sometimes involved accessing addi-
tional information.
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it. A few parents would have liked an email confirmation 
after they had completed the e- consent form.
I thought it was very easy. I think you’re probably go-
ing to get more responses that way from parents in 
this day and age. However, the downside is obvious-
ly you may not get that chance to discuss it. (Parent 
5—Yes)
According to feedback from nurses and schools not 
all parents found the intervention easy to access or 
use. Language barriers accounted for some difficul-
ties, but practical issues also played a role, for example, 
some parents had not signed up for the school parent 
mail system hence did not receive the weblink. Nurses 
also received a significant number of calls from parents 
reporting that the weblink would not open or that 
webpages froze. During an immunisation session one 
student stated: ‘my dad said I should have the vaccine, but 
he did not understand the whole google business about 
it’. In some instances, the weblink closed a few days prior 
to an immunisation session to give immunisation teams 
time to screen student information prior to sessions. This 
resulted in some parents who had missed the last sign- up 
date sending in written notes to confirm their consent/
non- consent for vaccination.
Outputs
Nurses access to e-consent forms and student information
The immunisation sessions at e- consent schools were 
affected by nurses not being able to access electronic 
information about students before and during sessions. 
The lower return of consent forms in e- consent schools 
also resulted in nurses reporting that they had to 
contact more parents than usual during immunisation 
sessions to obtain verbal consent. This had implications 
for the nurses’ workload distribution and the length of 
sessions. To manage these challenges immunisation 
teams increased the number of nurses and administrative 
assistants who attended e- consent school immunisation 
sessions.
…we had 80 consent forms outstanding at a big 
school. But, normally, if you only have a couple it’s 
fine. It meant us was making calls all morning, it took 
a nurse out of immunising to be able to do that, so 
that did have a big impact. (Immunisation Team 2)
Conducting phone calls during sessions was not 
straightforward. First, nurses had to rely on students (if 
they had phones with them) or staff to help them access 
correct contact details. Second, immunisations sessions 
were busy and noisy which impeded communication and 
privacy. Thirdly, it was not always possible to reach parents 
who were at work or out of the house during day- time 
hours. If parents were uncontactable the nurses assessed 
if students who wanted to be vaccinated had sufficient 
maturity and intelligence to understand and appraise the 
nature and implications of the proposed vaccination.12 13 
This process was time- consuming and not all nurses felt 
comfortable about vaccinating without verbal or written 
parent permission.
Transition: adapting to change and iterative development
The initial ‘buzz’ about the e- consent intervention 
decreased over time. While some staff remained posi-
tive and receptive to the implementation coordinators 
enthusiasm and vision, others expressed a sense of half- 
heartedness about having to adapt quickly from a known 
way of obtaining consent, although with flaws (eg, cost 
of paper, mileage clocked up in collecting paper consent 
forms from schools), to a new technology enabled way 
with some functional limitations in year 1 (see figure 1).
In the HRCH staff group interviews conducted in July 
2019 members of the immunisation teams reflected on 
lessons learnt from their experience of transitioning 
to a ‘brand new way of working’ over the past year. Key 
learning points from an internal organisational perspec-
tive were: (1) adopt right pace of progress when intro-
ducing new interventions with have several components, 
(2) be clear about which part of a multi- component inter-
vention is being piloted and implemented (eg, in year 1 it 
was primarily about the e- consent form), (3) importance 
of timely communication, quick thinking, and flexibility 
when things do not quite go to plan.
In terms of school engagement HRCH staff empha-
sised the importance of close collaboration to devise 
appropriate means of consent in different educational 
and social contexts. The right balance of responsibility 
between schools and immunisation teams needs to be 
negotiated to maintain positive working relationships and 
ensure that adolescents can access essential vaccines.
I would also say the idea of just changing to e- 
consent… schools need different things… it is really 
important to work with the school and a make sure 
that they are happy with everything and it suits that 
school, because some schools it might just not suit 
right now. It might suit them in a couple of years, but 
right now it just doesn’t work. (HRCH immunisers 
group interview, July 2019)
HRCH made several changes to the implementation 
of the e- consent intervention in year 2 (2018/2019) 
informed by evaluation findings (box 2).
Box 2 E- consent intervention implementation changes 
between Yr1 and Yr2
 ► Taking more time to engage (emails, phone calls and meetings) with 
schools in preparations to find the right level of involvement.
 ► Ensuring students receive a paper copy of the human papilloma 
virus adolescent programme leaflet produced by Public Health 
England in addition to information provided in the e- consent form.
 ► Pushing more for assemblies and contact with adolescent girls prior 
to the immunisation sessions.
 ► Providing ongoing training and mentoring of immunisation teams on 
use of the intervention.
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DISCUSSION
The pilot e- consent intervention had no detected impact 
on vaccine uptake and did not improve the return rate 
of consent forms in its first year of implementation. This 
could be interpreted as a negative result, however this 
would fail to account for the embedding process required 
before new technologies become (or do not become) 
routinely incorporated into everyday practice,14 and 
inherent difficulties in achieving high vaccine uptake in 
urban centres. Our findings demonstrate that the transi-
tion from paper to e- consent was not straightforward, and 
that staff and schools, though mainly open to change, 
took time to adapt. The transition was hampered by the 
reduced functionality of the information technology 
capability (intervention fidelity), limited staff training 
and engagement of schools. It is likely that this e- consent 
intervention would need to be used for more than 1 year 
to achieve any benefits to process efficiency and vaccine 
uptake.
This study starts to address an evidence gap and demon-
strates how real- time evaluation can support the iterative 
development of interventions essential for their longer- 
term integration. Key limitations include the lack of inter-
views with school staff to complement the feedback forms 
and not being able to access and interview parents who 
found the intervention more challenging to use.
The ‘normalisation process theory’ argues that new 
practices become routinely embedded as the result of 
people working, individually and collectively, to enact 
them. Enactment is promoted or inhibited through 
the operation of four mechanisms; coherence (sense 
making), cognitive participation (individual buy- in), 
collective action (joint effort) and reflexive monitoring 
(user appraisal).15 Sense making requires users to have 
a shared understanding concerning the purpose of an 
intervention, their responsibilities in its implementation, 
its potential benefits and the differences to existing prac-
tice.16 In our study, immunisation teams recognised the 
potential value of the intervention but were not clear 
about their specific responsibilities and schools had to 
make sense of the change in their role in consent logis-
tics. User buy- in is defined as user’s agreement to try out 
a new way of completing a task and their willingness to 
drive and sustain the implementation of a new inter-
vention.15 HRCH coordinators encouragement, ability 
to adapt when problems arose was critical to sustaining 
momentum throughout the implementation phase. Most 
schools bought into the concept of technology- enabled 
consent yet their willingness to sustain this change could 
have benefited from earlier collaboration between immu-
nisation teams, head teachers and link staff. Parents and 
student’s engagement with the e- consent intervention 
was variable. Parent interviewees accessed the online 
portal and were able to complete and submit the e- con-
sent form with ease. However, the significant difference 
in consent form return rate between e- consent and paper 
consent schools (73.3% (n=11) vs 91.6% (n=11), p=0.008) 
response rate (73.3%) indicated that this was not the case 
for all parents. Of additional concern was that the e- con-
sent intervention inadvertently bypassed some adoles-
cents’ information needs and related opportunity to talk 
to their parents about HPV vaccination. Collective action 
was evidenced when immunisation teams and schools 
worked together to make the follow- up of e- consent form 
non- response more targeted. Reflexive monitoring was 
facilitated by this real- time evaluation although more 
coproduction activities with HRCH staff, parents, school 
link staff and adolescents need to be integrated in subse-
quent evaluations.17 18
There is a need to streamline consent processes for 
adolescent immunisation and ensure that parents and 
adolescents are fully informed about these preventative 
measures. Electronic consent could be an effective option 
to achieve this. However, it needs to be tailored to specific 
contexts, and parents, schools and adolescents need to 
provide input in the development, implementation and 
evaluation of such technological interventions. Eval-
uations also need to factor in the time needed for new 
working practices to be fully integrated. Our experience 
suggests that to gain a complete and accurate assessment 
of the impact of new interventions evaluations need to 
collect data over more than one cycle of implementation. 
Introducing change that affects different actors requires 
all stakeholders to understand, buy in and work together 
in refining and coproducing complex behavioural 
interventions.
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